EU Representation
Representing non-EU based manufacturers in a successful EU Market entry and safeguarding their future across the entire community.
Learn MoreEU Product Registration
Ensuring compliance and registering products to be made available on the EU Market.
Learn MoreTechnical Documentation Review & EU Submissions
For your products to legally enter the EU Market and continue to circulate, you must have valid documentation.
Learn MoreEU Consultancy, Legal & Training
Find your way through a complicated EU marketplace with the support of a professional.
Learn MoreCareers at Obelis
Take the first step to a consulting career that helps build a safer Europe.
Learn MoreTestimonials
We have provided compliance and consulting services for more than 3000 manufacturers in over 60 countries, helping them successfully introduce products to the European market.
Learn MoreContact Us
Our head office is in Brussels and we have a network of offices in 11 different countries including the US and Israel.
Learn MoreInternational Representatives
An experienced EU compliance representative is just a call or meeting away…
Learn MoreObelis International Offices (OIO) Network
Obelis International Offices are independent partners who are able to provide our clients with solutions in other global markets of their choosing.
Learn MoreSpanish Agency on labelling medical devices in case of Brexit
The Spanish Agency of Drugs and Medical Devices (AEMPS) has established a transition period until June 30, 2020 to give manufacturers more time when changing service providers in view of Brexit.
The AEMPS had already released a guidance (PS, 8/2019) in April 2019 on the most important aspects to be taken into account once Brexit takes place. The main problem is having a Notified Body (NB) and/or an Authorized Representative (EAR) located in the UK. It is true that some manufacturers have already taken the necessary actions to be compliant and have found NB and EAR located in the EU27. Nonetheless, this implies that labelling and IFUs must be amended to reflect the change of NB and/or EAR to the one established in the EU27.
As changing the labels and IFUs to reflect the new EAR and/or NB is a challenging process, the AEMPS will grant manufacturers a transitional period until June the 30th to perform these changes.
Obelis, professional EAR based in Brussels can help you ensure compliance on the EU market post- Brexit.
Clàudia Miralles
RA Department
January 27th, 2020
Contact us today!
Get in touch